Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine augmentation to SRI treatment in obsessive-compulsive disorder
NL-OMON28722Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Nov 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in obsessive compulsive disorder (OCD) comparing SRI + quetiapine with SRI + placebo (2 arms). Primary endpoints: Change from baseline in Yale-Brown Obsessive Compulsive Scale and Responder rate. Started Nov 2003; status: active, not recruiting.
02
Drugs
quetiapine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NL-OMON28722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28722.